Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD

International Journal of Clinical Practice, Supplement

Volumn , Issue 120, 2001, Pages 14-23

  Erkinjuntti, T ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Brain pathology; Cognition; Function; Symptoms; Vascular dementia

Indexed keywords

NEUROTRANSMITTER;

ALZHEIMER DISEASE; BRAIN INJURY; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; FUNCTIONAL DISEASE; HUMAN; MULTIINFARCT DEMENTIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYMPTOM;

ALZHEIMER DISEASE; BRAIN INFARCTION; CEREBROVASCULAR DISORDERS; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 0034981618     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Prevalence and outcomes of vascular cognitive impairment
2. The prevalence of VaD in Europe: Facts and fragments from 1980-1990 studies
3. Epidemiology of VaD
4. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts
5. CerebroVaD, Pathophysiology, diagnosis and treatment
6. VaD: The role of cerebral infarcts
7. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia
8. Role of white matter lesions in cognitive impairment of vascular origin
9. Vascular factors and Alzheimer disease
10. Brain infarction and the clinical expression of Alzheimer's disease. The Nun study
11. Rethinking VaD
12. Blood pressure and dementia
13. Cognitive impairment in spontaneously hypertensive rats: Role of central nicotinic receptors. I
14. Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats
15. Animal models of VaD with emphasis on stroke-prone spontaneously hypertensive rats
16. Cerebrospinal fluid acetylcholine and choline in VaD of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia
17. The neurochemistry of VaD
18. Neurochemical abnormalities in VaD
19. Subtypes of VaD
20. Overlap between pathology of Alzheimer disease and VaD
21. Natural history of VaD
22. The cognitive syndrome of VaD: Implications for clinical trials
23. Conceptual background to vascular cognitive impairment
24. Vascular cognitive impairment
25. A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis
26. Memantine in treatment of mild to moderate dementia syndrome
27. Propentofylline in the treatment of Alzheimer's disease and VaD
28. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of VaD
29. Diagnosis of VaD and Alzheimer's disease
30. Types of multi-infarct dementia
31. Accuracy of the clinical diagnosis of VaD: A retrospective clinical and post-mortem neuropathological study
32. How acute brain failure becomes chronic. A view of the mechanisms and syndromes of dementia related to stroke
33. Binswanger disease: The history of a silent epidemic
34. Fronto-subcortical circuits and human behavior
35. The diagnosis of "mixed" dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC)
36. The behavioural neurology of multi-infarct dementia
37. A comparison of psychiatric symptoms in VaD and Alzheimer's disease
38. Perseverative behaviour in Alzheimer's disease and subcortical ischaemic VaD
39. Binswanger's disease: A review
40. Course characteristics in the differentiation of dementia of the Alzheimer type and multi-infarct dementia
41. Why do frontal lobe symptoms predominate in VaD with lacunes?
42. Subcortical symptoms predominate in VaD
43. Cognitive impairment after stroke: Frequency, patterns and relationship to functional abilities
44. VaD and Alzheimer's disease: Is there a difference? A comparison of symptoms by disease duration
45. Outcome measures for the study of activities of daily living in VaD
46. Alzheimer and VaDs and driving
47. Executive control function: A rational basis for the diagnosis of vascular dementia
48. Affective behavioural disturbances in Alzheimer's disease and ischaemic vascular disease
49. VaD: Diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop
50. Sensitivity and specificity of newly proposed clinical criteria for possible VaD
51. Comparison of seven sets of criteria used for the diagnosis of VaD
52. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS/ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
53. Epidemiology of VaD and stroke in Akita, Japan
54. Dementia after Stroke: Baseline frequency and risks in a hospitalised cohort
55. Dementia 3 months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort
56. Limitations of clinical criteria for the diagnosis of VaD in clinical trials. Is a focus on subcortical VaD a solution?
57. Research criteria for subcortical VaD in clinical trials